|
|
||||||||
Original Research Communications |
-Tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals1,2
1 From the Department of Medicine, Division of General Internal Medicine, University Hospital Nijmegen, Nijmegen, Netherlands.
Background:
-Tocopherol plays an important role in protecting LDL against oxidation. However, additional effects of
-tocopherol at the intracellular level may contribute to the clinical outcome of intervention studies.
Objective: We investigated whether
-tocopherol influences the inflammatory responses of immune cells in normolipidemic and hypertriglyceridemic subjects.
Design: RRR-
-Tocopherol was administered for 6 wk at a dose of 600 IU (402 mg)/d to 12 primary hypertriglyceridemic and 8 normolipidemic (fasting triacylglycerol >3.0 and <2.0 mmol/L, respectively) subjects. Cytokine production [tumor necrosis factor
(TNF-
), interleukin (IL)-1ß, and IL-8] by mononuclear cells and superoxide production by polymorphonuclear cells and in diluted whole blood were determined before and after the intervention.
Results: Cytokine and superoxide production did not differ significantly between hypertriglyceridemic and normolipidemic subjects.
-Tocopherol supplementation resulted in a 2- to 3-fold increase in the concentration of
-tocopherol in plasma and LDL. Whereas superoxide production in response to phorbol 12-myristate 13-acetate decreased in all subjects, response to oxidized LDL increased in 19 of 20 subjects. Response to opsonized zymosan before
-tocopherol supplementation was not significantly different from that after supplementation. Lipopolysaccharide-induced cytokine production by mononuclear cells decreased after supplementation with
-tocopherol.
Conclusions:
-Tocopherol differentially influences inflammatory responses of immune cells. These effects of
-tocopherol may be relevant in chronic inflammatory processes such as atherogenesis.
Key Words:
-Tocopherol superoxide chemiluminescence cytokines oxidized LDL hypertriglyceridemia men reactive oxygen species antioxidants
This article has been cited by other articles:
![]() |
S. E. Belisle, L. S. Leka, J. Delgado-Lista, P. F. Jacques, J. M. Ordovas, and S. N. Meydani Polymorphisms at Cytokine Genes May Determine the Effect of Vitamin E on Cytokine Production in the Elderly J. Nutr., October 1, 2009; 139(10): 1855 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sundl, M. Guardiola, G. Khoschsorur, R. Sola, J. C. Vallve, G. Godas, L. Masana, M. Maritschnegg, A. Meinitzer, N. Cardinault, et al. Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene 1131T>C variant and associations with plasma lipids and lipid peroxidation J. Lipid Res., November 1, 2007; 48(11): 2506 - 2513. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Singh, J. Tabibian, S. K. Venugopal, S. Devaraj, and I. Jialal Development of an In Vitro Screening Assay to Test the Antiinflammatory Properties of Dietary Supplements and Pharmacologic Agents Clin. Chem., December 1, 2005; 51(12): 2252 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Hall, Y. M. Jeanes, and J. K. Lodge Hyperlipidemic Subjects Have Reduced Uptake of Newly Absorbed Vitamin E into Their Plasma Lipoproteins, Erythrocytes, Platelets, and Lymphocytes, as Studied by Deuterium-Labeled {alpha}-Tocopherol Biokinetics J. Nutr., January 1, 2005; 135(1): 58 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dutta and S. K. Dutta Vitamin E and its Role in the Prevention of Atherosclerosis and Carcinogenesis: A Review J. Am. Coll. Nutr., August 1, 2003; 22(4): 258 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bruunsgaard, H. E. Poulsen, B. K. Pedersen, K. Nyyssonen, J. Kaikkonen, and J. T. Salonen Long-Term Combined Supplementations with {alpha}-Tocopherol and Vitamin C Have No Detectable Anti-Inflammatory Effects in Healthy Men J. Nutr., April 1, 2003; 133(4): 1170 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Jialal, S. Devaraj, and N. Kaul The Effect of {{alpha}}-Tocopherol on Monocyte Proatherogenic Activity J. Nutr., February 1, 2001; 131(2): 389S - 394. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |